SA
UTHR icon

Sanctuary Advisors’s United Therapeutics UTHR Stock Holding History

Sanctuary Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$918K Sell
1,695
-87
-5% -$49K ﹤0.01% 1509
2026
Q1 		$1.06M Sell
1,782
-496
-22% -$247K 0.01% 1299
2025
Q4 		$1.11M Buy
2,278
+893
+64% +$416K 0.01% 1262
2025
Q3 		$581K Buy
1,385
+174
+14% +$58.5K ﹤0.01% 1619
2025
Q2 		$348K Buy
1,211
+314
+35% +$93.8K ﹤0.01% 1832
2025
Q1 		$277K Sell
897
-10,180
-92% -$3.49M ﹤0.01% 1839
2024
Q4 		$3.9M Sell
11,077
-140
-1% -$51.5K 0.02% 593
2024
Q3 		$4.18M Buy
11,217
+321
+3% +$108K 0.03% 566
2024
Q2 		$2.55M Buy
+10,896
New +$2.88M 0.02% 704

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sanctuary Advisors's UTHR Position: Q2 2026 in Review

Sanctuary Advisors reduced its United Therapeutics (UTHR) stake by 4.9% in Q2 2026, selling an estimated $49K and leaving 1,695 shares worth $918K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

Sanctuary Advisors first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.18M in Q3 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sanctuary Advisors held 1,695 shares of United Therapeutics worth $918K as of Q2 2026.
  • Sanctuary Advisors sold 87 United Therapeutics shares in Q2 2026, an estimated $49K.
  • United Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1509 holding.
  • Sanctuary Advisors first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's United Therapeutics position peaked at $4.18M in Q3 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.